CENGILD MEDICAL |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.315 MYR | 0.00% |
|
-4.55% | -5.97% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Cengild Medical Berhad is a Malaysia-based investment holding company. The Company, through its subsidiary, is a healthcare provider specializing in the diagnosis and treatment of gastrointestinal and liver disease. The Company has around 36,588 sq. ft. medical center, which provides diagnostic and therapeutic facilities with 28 licensed beds, two fully equipped operating theatres, three endoscopy suites, and imaging facilities such as fibro scan, ultrasonography, computerized tomography (CT) scan, fluoroscopy, angiography equipment for endoscopic retrograde cholangiopancreatography (ERCP)s and other procedures. Its medical center's business activities comprise of consultant services and medical management services, which includes nursing services and clinical support services. In addition, it also offers 24-hour outpatient accident and emergency service, health screening, physiotherapy, and histopathology services. Its subsidiaries include Cengild Sdn. Bhd., and Galen Primer Sdn. Bhd.
Calendar
2024-05-27
- Q3 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -5.97% | 54.84M | |
| -21.49% | 16.01B | |
| +0.90% | 12.09B | |
| +1.00% | 11.21B | |
| +8.16% | 10.45B | |
| +17.84% | 7.87B | |
| -4.79% | 7.45B | |
| +22.00% | 7.27B | |
| +3.81% | 6.63B | |
| +43.14% | 4.41B |
- Stock Market
- Equities
- CENGILD Stock
- News Cengild Medical
- Cengild Medical's Profit, Revenue Rise in Fiscal Q1
